- OUTLOOK
Cells or drugs? The race to regenerate the heart
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 594, S16-S17 (2021)
doi: https://doi.org/10.1038/d41586-021-01457-2
This article is part of Nature Outlook: Heart health, an editorially independent supplement produced with the financial support of third parties. About this content.
References
Orlic, D. et al. Nature 410, 701–705 (2001).
Tehzeeb, J., Manzoor, A. & Ahmed, M. M. Cureus 11, e5959 (2019).
Arrell, D. K., Rosenow, C. S., Yamada, S., Behfar, A. & Terzic, A. npj Regen. Med. 5, 5 (2020).
Liu, Y.-W. et al. Nature Biotechnol. 36, 597–605 (2018).
Cao, J. & Poss, K. D. Nature Rev. Cardiol. 15, 631–647 (2018).
Smart, N. et al. Nature 474, 640–644 (2011).
McManus, S. et al. J. Mol. Cell. Cardiol. 140, 30–31 (2020).